Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmaceutical proteomics.

S Steiner1, N L Anderson

  • 1Large Scale Proteomics Corporation, Rockville, Maryland 20850-3338, USA. sandra.steiner@lsbc.com

Annals of the New York Academy of Sciences
|November 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diel rhythm of volatile emissions of males and females of the peach fruit fly Bactrocera zonata.

Journal of insect physiology·2019
Same author

[Sleep Apnea and Mechanical Ventilation - Impact on Clinical Course and Perioperative Management].

Pneumologie (Stuttgart, Germany)·2017
Same author

Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease.

Alimentary pharmacology & therapeutics·2016
Same author

Mechanism and Kinetics of Acetyl-Lysine Binding to Bromodomains.

Journal of chemical theory and computation·2015
Same author

Cardiac findings in obesity hypoventilation syndrome: is there a need for specific approach and evaluation?

Internal medicine journal·2015
Same author

Cyclic di-GMP acts as a cell cycle oscillator to drive chromosome replication.

Nature·2015
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Genomics and proteomics accelerate drug discovery by identifying more lead compounds. Integrating these technologies into development optimizes clinical trials for drug safety and efficacy using biological markers.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Genetics

Background:

  • Genomics and proteomics are integral to modern drug discovery.
  • These fields, alongside combinatorial chemistry and high-throughput screening, yield numerous potential lead compounds.
  • Integrating these advanced technologies into the drug development pipeline is crucial to prevent downstream bottlenecks.

Purpose of the Study:

  • To highlight the established role of genomics and proteomics in drug discovery.
  • To demonstrate the impact of these technologies on toxicology and lead selection.
  • To explore the emerging influence of these 'technology waves' on the clinical phase of drug development.

Main Methods:

  • Application of genomics and proteomics in identifying lead compounds.

Related Experiment Videos

  • Utilizing proteomics for mechanistic toxicology and lead selection.
  • Leveraging biological markers for clinical trial optimization.

    • Main Results:

    • Genomics and proteomics have significantly advanced lead compound identification.
    • Proteomics has proven effective in toxicological assessments and selecting promising drug candidates.
    • The integration of these technologies is beginning to influence clinical trial design.

    Conclusions:

    • Genomics and proteomics are essential tools in contemporary drug discovery and development.
    • Proteomics offers valuable insights into drug safety and efficacy.
    • Future clinical trials are expected to be optimized through biologically relevant markers derived from these technologies.